跳至主要内容
临床试验/IRCT20201205049612N1
IRCT20201205049612N1招募中3 期

Evaluation and comparison of the effect of haloperidol and quetiapine in the prevention of delirium in patients with end-stage cancer candidates receiving palliative care at home

Esfahan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Diagnosis of any type of end-stage cancer in the patient by the oncologist (discontinuation of therapeutic treatment with a prognosis of less than 6 months)
  • Conscious consent of the patient or his family to participate in the study

排除标准

  • Existence of major neurocagnetic disorder
  • Existence of delirium disorder according to DSM-V criteria by a psychiatric assistant and obtaining a score less than 5 in the ICDSC questionnaire
  • Any contraindications to the use of antipsychotic drugs

研究者

相似试验